Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Beloc Duriles
2. Beloc-duriles
3. Betaloc
4. Betaloc Astra
5. Betaloc-astra
6. Betalok
7. Cgp 2175
8. Cgp-2175
9. Cgp2175
10. H 93 26
11. H 93-26
12. H 9326
13. Lopressor
14. Metoprolol
15. Metoprolol Cr Xl
16. Metoprolol Cr-xl
17. Metoprolol Succinate
18. Seloken
19. Spesicor
20. Spesikor
21. Toprol
22. Toprol Xl
23. Toprol-xl
1. Beloc
2. Lopresor
3. Selopral
4. Betaloc
5. Prelis
6. 56392-17-7
7. Metoprolol Hemitartrate
8. Seloken
9. Cgp 2175e
10. W5s57y3a5l
11. Cgp-2175e
12. 1-isopropylamino-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) Dextro-tartrate Salt
13. Metoproferm
14. Selectadril
15. Arbralene
16. Azumetop
17. Beprolo
18. Bloksan
19. Cardoxone
20. Jeprolol
21. Kapodine
22. Mepolol
23. Metoberag
24. Metoberta
25. Metocard
26. Metolol
27. Metomerck
28. Metoprolin
29. Prolaken
30. Ritmolol
31. Sigaprolol
32. Topromel
33. Vasocardin
34. Bloxan
35. Lanoc
36. Metop
37. Metoprolol Acis
38. Metoprolol-rpm
39. Slow Lopresor
40. Metoprolol Atid
41. Metoprolol-wolf
42. Apo-metoprolol
43. Slow-lopresor
44. Metoprolol Al
45. Metoprolol Pb
46. Metoprolol Stada
47. Metoprolol Verla
48. Metoprolol-gry
49. Meto-isis
50. Metoprolol Basics
51. Proken M
52. Metoprolol Heumann
53. Meto Abz
54. Dsstox_cid_17248
55. Dsstox_rid_79315
56. Dsstox_gsid_37248
57. Metoprolol Apogepha
58. Metropress
59. Pms-metroprolol-b
60. Metoprolol-radiopharm
61. Metoprolol Tartrate (2:1)
62. Einecs 260-148-9
63. Unii-w5s57y3a5l
64. Nsc-757105
65. Ncgc00017119-01
66. (2r,3r)-2,3-dihydroxybutanedioic Acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
67. H 93/26
68. Cas-56392-17-7
69. Metoprolol Tartrate [usan:usp:jan]
70. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Hemi-l-tartrate
71. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol L-(+)-tartrate (2:1) (salt)
72. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Tartrate (2:1)
73. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, Tartrate (2:1)
74. Chebi:6906
75. Schembl1649321
76. Chembl3186768
77. Metoprolol Tartrate [mi]
78. Metoprolol Tartrate [jan]
79. Metoprolol Tartrate (jp17/usp)
80. Hms2097c08
81. Hms3714c08
82. Hms3884o12
83. Metoprolol Tartrate [usan]
84. Metoprolol Tartrate [vandf]
85. Metoprolol Tartrate [mart.]
86. (?)-metoprolol (+)-tartrate Salt
87. Tox21_110787
88. Tox21_113528
89. Metoprolol Tartrate [usp-rs]
90. Metoprolol Tartrate [who-dd]
91. S1856
92. 1-(isopropylamino)-3-[4-(beta-methoxyethyl)phenoxy]-2-propanol (+)-tartrate
93. Akos015961630
94. Tox21_110787_1
95. Ccg-220733
96. Nsc 757105
97. 2-propanol, 1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-, (+-)-, Tartrate (2:1)
98. Metoprolol Tartrate [orange Book]
99. Ncgc00021148-08
100. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1) (salt)
101. As-10163
102. Metoprolol Tartrate [ep Monograph]
103. Metoprolol Tartrate [usp Monograph]
104. Metoprolol Tartrat 100 Microg/ml In Water
105. M2555
106. Sw199199-2
107. D00601
108. D91610
109. Lopressidone Component Metoprolol Tartrate
110. Lopressor Hct Component Metoprolol Tartrate
111. Sr-01000872674
112. Metoprolol Tartrate Component Of Lopressidone
113. Sr-01000872674-1
114. Metoprolol Tartrate Component Of Lopressor Hct
115. Q27292351
116. (+/-)-metoprolol (+)-tartrate Salt, Analytical Standard
117. Metoprolol Tartrate 1.0 Mg/ml In Methanol (as Free Base)
118. (+/-)-metoprolol (+)-tartrate Salt, >=98% (titration), Powder
119. Metoprolol Tartrate, British Pharmacopoeia (bp) Reference Standard
120. Metoprolol Tartrate, European Pharmacopoeia (ep) Reference Standard
121. Metoprolol Tartrate, United States Pharmacopeia (usp) Reference Standard
122. 1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) Dextro-tartrate Salt
123. 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)- Amino]-2-propanol Tartrate
124. Metoprolol Tartrate, Pharmaceutical Secondary Standard; Certified Reference Material
125. (+/-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol L-(+)-tartrate (2:1) (salt)
126. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1) (salt)
127. Butanedioic Acid, 2,3-dihydroxy-, (2r,3r)-, Compd. With 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol (1:2)
Molecular Weight | 684.8 g/mol |
---|---|
Molecular Formula | C34H56N2O12 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 21 |
Exact Mass | 684.38332523 g/mol |
Monoisotopic Mass | 684.38332523 g/mol |
Topological Polar Surface Area | 217 Ų |
Heavy Atom Count | 48 |
Formal Charge | 0 |
Complexity | 349 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?